| BCBS Federal Medical & Drug | 2.01.100 Dry Needling of Trigger Points for Myofascial Pain | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.44 Germline Genetic Testing for Familial Cutaneous Malignant Melanoma | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.54 Molecular Genomic Profiling for Cancers of Unknown Primary | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.68 Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients with Cancer | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.86 Genetic Testing for Duchenne and Becker Muscular Dystrophy | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.87 Genetic Testing for Hereditary Hearing Loss | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.88 Genetic Testing for PTEN Hamartoma Tumor Syndrome | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.99 Genetic Testing for Hereditary Pancreatitis | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.103 Genetic Testing for Macular Degeneration | 2025-06-01 |
| BCBS Federal Medical & Drug | 2.04.109 Genetic Testing for Epilepsy | 2025-06-01 |